MeenakshiGHegdeMD

Pediatric Hematology & Oncology • Houston, TX

Physician

Join to view full profile

Dr. Hegde is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hegde's full profile

Already have an account?

Office
6701 Fannin St
Houston, TX 77030
Phone+1 832-824-1000

Education & Training

Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2009 - 2012
University of Illinois College of Medicine at ChicagoResidency, Pediatrics, 2006 - 2009
JSS Medical College MysoreClass of 2004

Certifications & Licensure

TX State Medical License 2010 - 2025
IL State Medical License 2006 - 2011
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors Start of enrollment: 2016 Dec 01
Completed
Phase 1

Publications & Presentations

PubMed

1 citations
Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors.
Anne Miller, Rachel Daum, Tao Wang, Mengfen Wu, Candise Tat
Cytotherapy. 2024-09-01
8 citations
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial.
Meenakshi Hegde, Shoba Navai, Christopher DeRenzo, Sujith K Joseph, Khaled Sanber
Nature Cancer. 2024-06-01
4 citations
Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival.
Caridad Martinez, Paibel Aguayo-Hiraldo, Natalia Chaimowitz, Lisa Forbes, Nicholas Rider
Blood Advances. 2023-05-09

Journal Articles

Retraction Note: A Homing System Targets Therapeutic T Cells to Brain Cancer
Nabil Ahmed, Fong W Lam, Meenakshi Hegde, Jordan S Orange, Thomas Shum, Rakesh K Jain, Nature

Press Mentions

Baylor College of Medicine Receives More Than $17 Million from CPRITAugust 21st, 2024
The Faris Foundation Grant Funds Research for Advanced Sarcoma Clinical TrialDecember 4th, 2020
$HER2 CAR T Therapy Dramatically Improves Child’s Refractory Cancer$
HER2 CAR T Therapy Dramatically Improves Child’s Refractory CancerJuly 16th, 2020
Join now to see all